Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters











Publication year range
1.
Polymers (Basel) ; 14(3)2022 Jan 29.
Article in English | MEDLINE | ID: mdl-35160550

ABSTRACT

This paper presents a three-year study of the influence of different amounts of nitrogen on the properties of flax plants and fibres. At the same time, the acclimatization ability of five different cultivars of fibre flax was estimated through the valorisation of their morphological (technical stem length, stem thickness) and physical-mechanical properties of the fibres (length, fineness, tenacity). Cultivar trials with fibre flax were set up across three years (2008-2010) at the following locations: the experimental fields of the Faculty of Agriculture in Zagreb on anthropogenized Eutric Cambisol and the College of Agriculture at Krizevci on pseudogley on level terrain. The selected cultivars were fertilized without and with different nitrogen rates (0, 30, 60 and 90 kg/ha) in different time. The trials were carried out according to the RCBD in four replications. According to the results of the three-year study of flax and fibres, significant differences were established among the cultivars and among the added nitrogen rates under study. Based on the results of the morphological and textile-technological properties of flax, the cultivars Viola and Agatha achieved higher values at the location of Krizevci, where it was not necessary to add more than 30 kg N/ha.

2.
Food Technol Biotechnol ; 56(4): 562-572, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30923453

ABSTRACT

Heating the rapeseed prior to the oil extraction is conducted to increase the oil yield but it can also induce changes of various components of the seed. These changes may affect the composition of the volatile and non-volatile compounds of produced virgin rapeseed oil. The aim of our study is to determine the impact of different conditioning temperatures (60, 80 and 100 °C) on the quality, nutritional value, aroma profile and sensory characteristics of virgin rapeseed oil. Conditioning the seeds at all three temperatures had no influence on the quality and major nutritional components (fatty acids and tocopherols) of the produced oil. However, temperature increase caused an exponential increase of canolol and significant changes in the aroma and sensory profile of the produced oil samples. The dominant volatile compounds of cold-pressed and virgin oil produced at 60 °C were enzymatic degradation products of glucosinolates (isothiocyanates and epithionitriles), responsible for pronounced seed-like flavour of these types of oil. Increasing production temperature deactivated enzymes and caused thermal decomposition of seed components and increment of nitriles, aldehydes, pyrazines and furanes, carriers of nutty and roasty flavour. These results can help producers to design virgin rapeseed oil with specific and desirable sensory characteristics.

3.
Pest Manag Sci ; 73(10): 2174-2183, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28449326

ABSTRACT

BACKGROUND: Owing to the changing climate, narrow crop rotation, and changes in insecticide application practice, sugar beet weevil (SBW) (Bothynoderes punctiventris Germar) has become the most important economic pest in sugar beet. To develop alternative control methods, an area-wide (AW) control program using aggregation pheromones was implemented over 4 years on an area of 6 and 14.8 km2 in east Croatia. RESULTS: The mass trapping of SBW on the 'old' sugar beet fields reduced the population from 0.73% to 11.59%. Owing to the strong attack, mass trapping was not effective enough to avoid an insecticide application. However, it significantly reduced the number of insecticide applications, the amount of insecticide used, and the damage compared to the fields outside the mass trapping area. CONCLUSION: This is the first study to implement an AW program for SBW. It may not be possible to state from this study that trapping alone can reduce the SBW population below the economic threshold level. However, the data do suggest that trapping can play an important role in the reduction of insecticide applications and in creating an integrated pest management plan for dealing with SBW under similar circumstances. © 2017 Society of Chemical Industry.


Subject(s)
Insect Control , Pheromones , Weevils , Animals , Beta vulgaris/growth & development , Croatia , Insect Control/methods
4.
Purinergic Signal ; 11(1): 79-85, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25358454

ABSTRACT

Adenosine A3 receptor knockout (A3AR KO) mice and their wild-type (WT) counterparts were compared from the point of view of their abilities to survive exposures to lethal doses of γ-radiation belonging to the range of radiation doses inducing the bone marrow acute radiation syndrome. Parameters of cumulative 30-day survival (experiment using a midlethal radiation dose) or cumulative 11-day survival (experiment using an absolutely lethal radiation dose), and of mean survival time were evaluated. The values of A3AR KO mice always reflected their higher survival in comparison with WT ones, the P values being above the limit for statistical significance after the midlethal radiation dose and standing for statistical significance after the absolutely lethal radiation dose. This finding was considered surprising, taking into account the previously obtained findings on defects in numbers and functional properties of peripheral blood cells in A3AR KO mice. Therefore, previous hematological analyses of A3AR KO mice were supplemented in the present studies with determination of serum levels of the granulocyte colony-stimulating factor, erythropoietin, and thrombopoietin. Though distinct differences in these parameters were observed between A3AR KO and WT mice, none of them could explain the relatively high postirradiation survival of A3AR KO mice. Further studies on these mice comprising also those on other than hemopoietic tissues and organs can help to clarify their relative radioresistance.


Subject(s)
Acute Radiation Syndrome/mortality , Receptor, Adenosine A3/genetics , Acute Radiation Syndrome/genetics , Acute Radiation Syndrome/metabolism , Animals , Mice , Mice, Knockout , Receptor, Adenosine A3/metabolism , Survival Rate
5.
Food Technol Biotechnol ; 53(4): 496-504, 2015 Dec.
Article in English | MEDLINE | ID: mdl-27904385

ABSTRACT

The objective of this study is to compare the influence of genotype, environmental conditions and processing methods after maturation and harvesting of four varieties of flaxseed (Altess, Biltstar, Niagara and Oliwin) on the levels of tocochromanols, carotenoids and chlorophyll in flaxseed oil. Samples were produced by cold pressing of dry seeds and seeds heated for 30 min at 60 °C. Temperature, sunshine and rainfall were primary environmental conditions included. Grand mean of mass fraction of γ-tocopherol was (522±29), of plastochromanol-8 (305±2) and total tocochromanols (831±3) mg per kg of oil. The highest levels of these compounds and strongest antioxidant activity were found in cold- -pressed oil of Biltstar variety. During seed maturation, levels of γ-tocopherol and plastochromanol-8 increased with average temperature and total sunshine and decreased with total rainfall. Fifth week after flowering was identified as the maturation period with best climate conditions to achieve optimal tocochromanol content. Grand mean of mass fraction of carotenoids expressed as ß-carotene was (1.83±0.01) and of chlorophyll expressed as pheophytin a (0.43±0.10) mg per kg of oil. Altess variety had the highest levels of pigments. Antioxidant activity decreased with the increase of chlorophyll, while correlations with carotenoids were not determined. Generally, oil obtained by cold pressing had higher levels of tocochromanols and lower levels of pigments but similar antioxidant activity to the oil after seed conditioning. The results of this study contribute to identifying the flaxseed variety that is the best for oil production with the highest antioxidant activity and nutritive value, and provide better understanding of tocochromanol biosynthesis depending on different climate conditions.

6.
Purinergic Signal ; 10(3): 509-14, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24763970

ABSTRACT

The role of the adenosine A3 receptor in hematopoiesis was studied using adenosine A3 receptor knockout (A3AR KO) mice. Hematological parameters of peripheral blood and femoral bone marrow of irradiated and untreated A3AR KO mice and their wild-type (WT) counterparts were investigated. Irradiation of the mice served as a defined hematopoiesis-damaging means enabling us to evaluate contingent differences in the pattern of experimentally induced hematopoietic suppression between the A3AR KO mice and WT mice. Defects were observed in the counts and/or functional parameters of blood cells in the A3AR KO mice. These defects include statistically significantly lower values of blood neutrophil and monocyte counts, as well as those of mean erythrocyte volume, mean erythrocyte hemoglobin, blood platelet counts, mean platelet volume, and plateletcrit, and can be considered to bear evidence of the lack of a positive role played by the adenosine A3 receptor in the hematopoietic system. Statistically significantly increased values of the bone marrow parameters studied in A3AR KO mice (femoral bone marrow cellularity, granulocyte/macrophage progenitor cells, and erythrocyte progenitor cells) can probably be explained by compensatory mechanisms attempting to offset the disorders in the function of blood elements in these mice. The pattern of the radiation-induced hematopoietic suppression was very similar in A3AR KO mice and their WT counterparts.


Subject(s)
Hematopoiesis/physiology , Hematopoietic Stem Cells/metabolism , Leukocytes, Mononuclear/metabolism , Receptor, Adenosine A3/deficiency , Animals , Mice , Mice, Inbred C57BL , Mice, Knockout
7.
Molecules ; 19(4): 4770-8, 2014 Apr 16.
Article in English | MEDLINE | ID: mdl-24743934

ABSTRACT

This article concisely summarizes data on the action of one of the principal and best known growth factors, the granulocyte colony-stimulating factor (G-CSF), in a mammalian organism exposed to radiation doses inducing acute radiation syndrome. Highlighted are the topics of its real or anticipated use in radiation accident victims, the timing of its administration, the possibilities of combining G-CSF with other drugs, the ability of other agents to stimulate endogenous G-CSF production, as well as of the capability of this growth factor to ameliorate not only the bone marrow radiation syndrome but also the gastrointestinal radiation syndrome. G-CSF is one of the pivotal drugs in the treatment of radiation accident victims and its employment in this indication can be expected to remain or even grow in the future.


Subject(s)
Acute Radiation Syndrome/drug therapy , Granulocyte Colony-Stimulating Factor/therapeutic use , Acute Radiation Syndrome/pathology , Animals , Bone Marrow/pathology , Bone Marrow/radiation effects , Drug Administration Schedule , Drug Therapy, Combination , Granulocyte Colony-Stimulating Factor/biosynthesis , Humans , Interleukin-3/therapeutic use , Membrane Proteins/therapeutic use , Radioactive Hazard Release , Recombinant Proteins/therapeutic use , Stem Cell Factor/therapeutic use , Thrombopoietin/therapeutic use , Time Factors
8.
Radiat Environ Biophys ; 53(1): 211-5, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24263216

ABSTRACT

There exists a requirement for drugs which would be useful in therapy of an acute radiation damage of a mammalian organism. The aim of the study was to evaluate survival parameters in mice exposed to a lethal γ-ray dose of 8.5 Gy and treated with single doses of an adenosine A(3) receptor agonist, IB-MECA, or a cyclooxygenase-2 (COX-2) inhibitor, meloxicam, administered alone or in a combination early after irradiation, i.e., 0.5 and 1 h post-irradiation, respectively. The assessed parameters were the mean survival time (MST) and the cumulative percentage 30-day survival (CPS). Administrations of single intraperitoneal doses of either IB-MECA 0.5 h post-irradiation or meloxicam 1 h post-irradiation resulted in statistically significant increases of MST in comparison with the control irradiated mice. Combined administration of IB-MECA and meloxicam was found to be the only treatment statistically enhancing the parameter of CPS and to lead to the most expressive increase in MST of the experimental mice. The findings add new knowledge on the action of an adenosine A3 receptor agonist and a COX-2 inhibitor in an irradiated mammalian organism and suggest the potential of both the investigated drugs in the treatment of the acute radiation damage.


Subject(s)
Adenosine/analogs & derivatives , Cyclooxygenase 2/metabolism , Gamma Rays/adverse effects , Receptor, Adenosine A3/metabolism , Thiazines/pharmacology , Thiazoles/pharmacology , Whole-Body Irradiation/adverse effects , Adenosine/pharmacology , Adenosine A3 Receptor Agonists/pharmacology , Animals , Cyclooxygenase 2 Inhibitors/pharmacology , Drug Interactions , Male , Meloxicam , Mice , Radiation-Protective Agents/pharmacology , Survival Rate , Time Factors
9.
Purinergic Signal ; 9(2): 207-14, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23242571

ABSTRACT

This study continues our earlier findings on the hematopoiesis-modulating effects of adenosine A1 and A3 receptor agonists that were performed on committed hematopoietic progenitor and precursor cell populations. In the earlier experiments, N (6)-cyclopentyladenosine (CPA), an adenosine A1 receptor agonist, was found to inhibit proliferation in the above-mentioned hematopoietic cell systems, whereas N (6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA), an adenosine A3 receptor agonist, was found to stimulate it. The topic of this study was to evaluate the possibility that the above-mentioned adenosine receptor agonists modulate the behavior of early hematopoietic progenitor cells and hematopoietic stem cells. Flow cytometric analysis of hematopoietic stem cells in mice was employed, as well as a functional test of hematopoietic stem and progenitor cells (HSPCs). These techniques enabled us to study the effect of the agonists on both short-term repopulating ability and long-term repopulating ability, representing multipotent progenitors and hematopoietic stem cells, respectively. In a series of studies, we did not find any significant effect of adenosine agonists on HSPCs in terms of their numbers, proliferation, or functional activity. Thus, it can be concluded that CPA and IB-MECA do not significantly influence the primitive hematopoietic stem and progenitor cell pool and that the hematopoiesis-modulating action of these adenosine receptor agonists is restricted to more mature compartments of hematopoietic progenitor and precursor cells.


Subject(s)
Hematopoiesis/physiology , Hematopoietic Stem Cells/physiology , Multipotent Stem Cells/physiology , Receptor, Adenosine A1/metabolism , Receptor, Adenosine A3/metabolism , Animals , Flow Cytometry , Hematopoiesis/drug effects , Hematopoietic Stem Cells/drug effects , Mice , Mice, Inbred C57BL , Multipotent Stem Cells/drug effects , Purinergic P1 Receptor Agonists/pharmacology
10.
Molecules ; 17(5): 5615-25, 2012 May 10.
Article in English | MEDLINE | ID: mdl-22576231

ABSTRACT

The presented review summarizes experimental data obtained with a mouse model when investigating the relationship between inhibition of prostaglandin production and hematopoiesis. While prostaglandin E2 acts in a negative feedback control of myelopoiesis, inhibition of cyclooxygenases, responsible for its production, shifts the feedback to positive control. Based on these relationships, agents inhibiting cyclo-oxygenases, known as non-steroidal anti-inflammatory drugs (NSAIDs), can activate hematopoiesis and be protective or curative under myelosuppressive states. The effectiveness of therapeutic use of NSAIDs in these situations is expressive especially under the selective inhibition of cyclooxygenase-2 (COX-2), when undesirable side effects of cyclooxygenase-1 inhibition, like gastrointestinal damage, are absent. The effects of the clinically approved selective COX-2 inhibitor, meloxicam, were investigated and demonstrated significant hematopoiesis-stimulating and survival-enhancing actions of this drug in sublethally or lethally γ-irradiated mice. These effects were connected with the ability of meloxicam to increase serum levels of the granulocyte colony-stimulating factor. It can be inferred from these findings that selective COX-2 inhibitors might find their use in the treatment of myelosuppressions of various etiologies.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cyclooxygenase 2 Inhibitors/therapeutic use , Hematopoiesis/drug effects , Myelopoiesis/radiation effects , Thiazines/therapeutic use , Thiazoles/therapeutic use , Animals , Cyclooxygenase 2/metabolism , Dinoprostone/metabolism , Feedback, Physiological/drug effects , Feedback, Physiological/radiation effects , Gamma Rays , Granulocyte Colony-Stimulating Factor/biosynthesis , Granulocyte Colony-Stimulating Factor/blood , Hematopoiesis/radiation effects , Humans , Meloxicam , Mice , Myelopoiesis/drug effects
11.
Molecules ; 16(9): 7969-79, 2011 Sep 15.
Article in English | MEDLINE | ID: mdl-21921869

ABSTRACT

ß-glucans are cell wall constituents of bacteria, yeast, fungi, and plants. They are not expressed in mammalian cells, but they are recognized by mammalian cells as pathogen-associated molecular patterns by pattern recognition receptors and thus act as biological response modifiers. This review summarizes data on the hematopoiesis-stimulating effects of ß-glucans, as well as on their ability to enhance bone marrow recovery after an injury. ß-glucans have been shown to support murine hematopoiesis suppressed by ionizing radiation or cytotoxic anti-cancer therapy. They also enhance stem cell homing and engraftment. Basically, two forms of ß-glucan preparations have been investigated, namely particulate and soluble ones. ß-glucans are generally well tolerated, the particulate forms showing a higher incidence of undesirable side effects. Taken together, the hematopoiesis-stimulating properties of ß-glucans predetermine these biological response modifiers to ever increasing use in human medicinal practice.


Subject(s)
Hematinics/pharmacology , Hematopoiesis/drug effects , beta-Glucans/pharmacology , Anemia/chemically induced , Anemia/drug therapy , Animals , Antineoplastic Agents/adverse effects , Dosage Forms , Hematinics/adverse effects , Hematinics/therapeutic use , Hematopoiesis/radiation effects , Humans , Radiotherapy/adverse effects , beta-Glucans/adverse effects , beta-Glucans/therapeutic use
12.
Biomed Pharmacother ; 65(6): 427-31, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21719245

ABSTRACT

Mouse hematopoiesis, suppressed by a sublethal dose of ionizing radiation, was the target for combined therapy with a cyclooxygenase-2 (COX-2) inhibitor meloxicam and an adenosine A3 receptor agonist IB-MECA. The drugs were administered in an early postirradiation treatment regimen: meloxicam was given in a single dose 1hour after irradiation, IB-MECA in two doses 24 and 48hours after irradiation. Treatment-induced changes in several compartments of hematopoietic progenitor and precursor cells of the bone marrow were evaluated on day 3 after irradiation. Values of hematopoietic progenitor cells for granulocytes/macrophages and erythrocytes (GM-CFC and BFU-E, respectively), as well as those of proliferative granulocytic cells were found to be significantly higher in the mice treated with the drug combination in comparison to irradiated controls and attained the highest increase factors of 1.6, 1.6, and 2.6, respectively. The study emphasizes the significance of the combined treatment of suppressed hematopoiesis with more agents. Mechanisms of the action of the individual compounds of the studied drug combination and of their joint operation are discussed.


Subject(s)
Adenosine A3 Receptor Agonists/therapeutic use , Cyclooxygenase 2 Inhibitors/therapeutic use , Gamma Rays/adverse effects , Hematopoiesis/drug effects , Radiation Injuries, Experimental/drug therapy , Adenosine/administration & dosage , Adenosine/analogs & derivatives , Adenosine/therapeutic use , Adenosine A3 Receptor Agonists/administration & dosage , Animals , Cell Count , Crosses, Genetic , Cyclooxygenase 2 Inhibitors/administration & dosage , Drug Therapy, Combination , Erythroid Precursor Cells/drug effects , Erythroid Precursor Cells/radiation effects , Granulocyte Colony-Stimulating Factor/blood , Granulocyte Precursor Cells/drug effects , Granulocyte Precursor Cells/radiation effects , Hematinics/administration & dosage , Hematinics/therapeutic use , Hematopoiesis/radiation effects , Hematopoietic Stem Cells/drug effects , Hematopoietic Stem Cells/radiation effects , Male , Meloxicam , Mice , Mice, Inbred CBA , Radiation Injuries, Experimental/blood , Radiation Injuries, Experimental/pathology , Thiazines/administration & dosage , Thiazines/therapeutic use , Thiazoles/administration & dosage , Thiazoles/therapeutic use , Whole-Body Irradiation
13.
Molecules ; 16(1): 675-85, 2011 Jan 17.
Article in English | MEDLINE | ID: mdl-21242946

ABSTRACT

The review summarizes data evaluating the role of adenosine receptor signaling in murine hematopoietic functions. The studies carried out utilized either non-selective activation of adenosine receptors induced by elevation of extracellular adenosine or by administration of synthetic adenosine analogs having various proportions of selectivity for a particular receptor. Numerous studies have described stimulatory effects of non-selective activation of adenosine receptors, manifested as enhancement of proliferation of cells at various levels of the hematopoietic hierarchy. Subsequent experimental approaches, considering the hematopoiesis-modulating action of adenosine receptor agonists with a high level of selectivity to individual adenosine receptor subtypes, have revealed differential effects of various adenosine analogs. Whereas selective activation of A1 receptors has resulted in suppression of proliferation of hematopoietic progenitor and precursor cells, that of A3 receptors has led to stimulated cell proliferation in these cell compartments. Thus, A1 and A3 receptors have been found to play a homeostatic role in suppressed and regenerating hematopoiesis. Selective activation of adenosine A3 receptors has been found to act curatively under conditions of drug- and radiation-induced myelosuppression. The findings in these and further research areas will be summarized and mechanisms of hematopoiesis-modulating action of adenosine receptor agonists will be discussed.


Subject(s)
Hematopoiesis/drug effects , Receptors, Purinergic P1/drug effects , Animals , Humans , Signal Transduction
14.
Exp Biol Med (Maywood) ; 235(8): 928-31, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20660092

ABSTRACT

In this study we examined differences in selected indices of granulopoiesis in outbred, F(1) hybrid and inbred mouse strains. Specifically, serum granulocyte colony-stimulating factor (G-CSF) levels, numbers of marrow granulocyte-macrophage progenitor cells and morphologically recognizable proliferative marrow granulocytic precursor cells were evaluated. These parameters were determined in untreated controls, and in mice exposed either to a non-specific stimulus (injection of saline) or to a granulopoiesis-enhancing stimulus (administration of a cyclooxygenase-2 inhibitor, meloxicam). Lower levels of G-CSF were detectable in the outbred ICR mice, which also demonstrated an enhanced response to both types of the stimuli. Considering the fact that outbred mice are closer to natural mammalian populations, including human ones, the possibility of using outbred mice, instead of the often used inbred strains, for experiments evaluating the effects of pharmacological interventions on hematopoiesis should be investigated.


Subject(s)
Granulocytes/cytology , Hybridization, Genetic/genetics , Inbreeding , Myelopoiesis/physiology , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , Cell Proliferation/drug effects , Cyclooxygenase Inhibitors/pharmacology , Granulocyte Colony-Stimulating Factor/blood , Granulocyte-Macrophage Colony-Stimulating Factor/blood , Granulocyte-Macrophage Progenitor Cells , Granulocytes/drug effects , Humans , Injections, Intraperitoneal , Male , Meloxicam , Mice , Mice, Inbred Strains , Myelopoiesis/drug effects , Sodium Chloride/administration & dosage , Sodium Chloride/pharmacology , Thiazines/pharmacology , Thiazoles/pharmacology
15.
Int J Radiat Biol ; 86(8): 649-56, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20586541

ABSTRACT

PURPOSE: Research areas of 'post-exposure treatment' and 'cytokines and growth factors' have top priority among studies aimed at radiological nuclear threat countermeasures. The experiments were aimed at testing the ability of N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA), an adenosine A(3) receptor agonist, to modulate hematopoiesis in sublethally irradiated mice, when administered alone or in a combination with granulocyte colony-stimulating factor (G-CSF) in a two-day post-irradiation treatment regimen. MATERIALS AND METHODS: A complete analysis of hematopoiesis including determination of numbers of bone marrow hematopoietic progenitor and precursor cells, as well as of numbers of peripheral blood cells, was performed. The outcomes of the treatment were assessed at days 3 to 22 after irradiation. RESULTS: IB-MECA alone has been found to induce a significant elevation of numbers of bone marrow granulocyte-macrophage progenitor cells (GM-CFC) and peripheral blood neutrophils. IB-MECA given concomitantly with G-CSF increased significantly bone marrow GM-CFC and erythroid progenitor cells (BFU-E) in comparison with the controls and with animals administered each of the drugs alone. CONCLUSIONS: The findings suggest the ability of IB-MECA to stimulate hematopoiesis and to support the hematopoiesis-stimulating effects of G-CSF in sublethally irradiated mice.


Subject(s)
Granulocyte Colony-Stimulating Factor/pharmacology , Hematopoiesis/drug effects , Receptor, Adenosine A3/physiology , Adenosine/analogs & derivatives , Adenosine/pharmacology , Animals , Erythroid Precursor Cells/radiation effects , Granulocyte Colony-Stimulating Factor/blood , Male , Mice , Mice, Inbred C57BL , Whole-Body Irradiation
16.
Appl Radiat Isot ; 68(4-5): 676-8, 2010.
Article in English | MEDLINE | ID: mdl-20036568

ABSTRACT

This paper reports on the formation of silver nanoparticles initiated by gamma and UV radiation in various aqueous solutions. Inorganic precursors were used for radiation and/or photochemical reduction of Ag(+) ions to a metallic form. The influence of various parameters on the nucleation and formation of colloid particles was studied. Attention was also focused on the composition of the irradiated solution. Aliphatic alcohols were used as scavengers of OH radicals and other oxidizing species. The influence of the stabilizers on the formation and stability of the nanoparticles was studied.


Subject(s)
Metal Nanoparticles/chemistry , Metal Nanoparticles/radiation effects , Silver/chemistry , Silver/radiation effects , Water/chemistry , Colloids/chemistry , Colloids/radiation effects , Oxidation-Reduction/radiation effects , Radiation Dosage
17.
Exp Biol Med (Maywood) ; 233(7): 897-900, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18445770

ABSTRACT

Two adenosine receptor agonists, N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) and N6-cyclopentyladenosine (CPA), which selectively activate adenosine A3 and A1 receptors, respectively, were tested for their ability to influence proliferation of granulocytic and erythroid cells in femoral bone marrow of mice using morphological criteria. Agonists were given intraperitoneally to mice in repeated isomolar doses of 200 nmol/kg. Three variants of experiments were performed to investigate the action of the agonists under normal resting state of mice and in phases of cell depletion and subsequent regeneration after treatment with the cytotoxic drug 5-fluorouracil. In the case of granulopoiesis, IB-MECA 1) increased by a moderate but significant level proliferation of cells under normal resting state; 2) strongly increased proliferation of cells in the cell depletion phase; but 3) did not influence cell proliferation in the regeneration phase. CPA did not influence cell proliferation under normal resting state and in the cell depletion phase, but strongly suppressed the overshooting cell proliferation in the regeneration phase. The stimulatory effect of IB-MECA on cell proliferation of erythroid cells was observed only when this agonist was administered during the cell depletion phase. CPA did not modulate erythroid proliferation in any of the functional states investigated, probably due to the lower demand for cell production as compared with granulopoiesis. The results indicate opposite effects of the two adenosine receptor agonists on proliferation of hematopoietic cells and suggest the plasticity and homeostatic role of the adenosine receptor expression.


Subject(s)
Adenosine A1 Receptor Agonists , Adenosine A3 Receptor Agonists , Adenosine/analogs & derivatives , Cell Proliferation/drug effects , Hematopoietic Stem Cells/cytology , Homeostasis/physiology , Adenosine/pharmacology , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , Bone Marrow Cells/metabolism , Dose-Response Relationship, Drug , Erythroid Cells/cytology , Erythroid Cells/drug effects , Erythroid Cells/metabolism , Granulocytes/cytology , Granulocytes/drug effects , Granulocytes/metabolism , Hematopoietic Stem Cells/drug effects , Hematopoietic Stem Cells/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Receptor, Adenosine A1/metabolism , Receptor, Adenosine A3/metabolism
18.
Biomed Pharmacother ; 61(6): 356-9, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17383145

ABSTRACT

The present study was performed to define the optimum conditions of the stimulatory action of the adenosine A(3) receptor agonist, N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA), on bone marrow hematopoiesis in mice. Effects of 2-day treatment with IB-MECA given at single doses of 200nmol/kg twice daily were investigated in normal mice and in mice whose femoral bone marrow cells were either depleted or regenerating after pretreatment with the cytotoxic drug 5-fluorouracil. Morphological criteria were used to determine the proliferation state of the granulocytic and erythroid cell systems. Significant negative correlation between the control proliferation state and the increase of cell proliferation after IB-MECA treatment irrespective of the cell lineage investigated was found. The results suggest the homeostatic character of the induced stimulatory effects and the need to respect the functional state of the target tissue when investigating effects of adenosine receptor agonists under in vivo conditions.


Subject(s)
Adenosine A3 Receptor Agonists , Hematopoiesis/drug effects , Homeostasis/drug effects , Adenosine/analogs & derivatives , Adenosine/pharmacology , Animals , Bone Marrow/physiology , Bone Marrow Cells/drug effects , Cell Lineage , Cell Proliferation/drug effects , Erythroid Cells/drug effects , Granulocytes/drug effects , Male , Mice , Mice, Inbred Strains
19.
Eur J Pharmacol ; 538(1-3): 163-7, 2006 May 24.
Article in English | MEDLINE | ID: mdl-16643889

ABSTRACT

The purpose of the experiments reported was to investigate effects of N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA), a selective adenosine A(3) receptor agonist, on the granulocytic system in femoral marrow of mice depleted by the cytotoxic drug 5-fluorouracil. In the phase of the highest cell depletion IB-MECA was injected i.p. at single doses of 200 nmol/kg given either once or twice daily in 2- and 4-day regimens starting on day 1 after 5-fluorouracil administration; the effects were evaluated on days 3 and 5, respectively. The general effect of IB-MECA in all these experiments was an enhancement of the counts of morphologically recognizable proliferative granulocytic cells, interpreted as evidence of the differentiation of committed progenitor cells. A more expressive effect was observed after IB-MECA injected twice daily. It was found that the induction of the strong differentiation pressures by IB-MECA given twice daily shortly after 5-fluorouracil treatment can be counterproductive due to the preponderance of differentiaton processes over the proliferation control. In additional experiments, it has been shown that the use of the 2-day administration of IB-MECA given twice daily in the recovery phase, i.e., on days 5 and 6 after 5-fluorouracil administration, does not induce stimulatory effects. Thus, the dosing and timing of IB-MECA treatment determines its effectivity in stimulating granulopoiesis under conditions of myelosuppression.


Subject(s)
Adenosine A3 Receptor Agonists , Adenosine/analogs & derivatives , Bone Marrow Cells/drug effects , Fluorouracil/pharmacology , Granulocytes/drug effects , Adenosine/administration & dosage , Adenosine/pharmacology , Animals , Bone Marrow Cells/cytology , Cell Proliferation/drug effects , Fluorouracil/administration & dosage , Granulocytes/cytology , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/pharmacology , Injections, Intraperitoneal , Male , Mice , Time Factors
20.
Eur J Pharmacol ; 507(1-3): 1-6, 2005 Jan 10.
Article in English | MEDLINE | ID: mdl-15659287

ABSTRACT

Effects of N6-cyclopentyladenosine (CPA), the selective adenosine A1 receptor agonist, on bone marrow haematopoietic progenitor cells for granulocytes and macrophages (CFC-GM) were investigated by utilizing the model of haematopoietic damage induced by 5-fluorouracil. Experiments were performed in vivo on B10CBAF1 mice. A single i.p. injection of CPA at the optimum dose of 200 nmol/kg administered 22 h before a single injection of 5-fluorouracil (100 mg/kg, i.p.) protected CFC-GM against the cytotoxic damage as determined 4 days later. Isomolar doses of the selective agonists for adenosine A2A receptors, i.e. 2-p-(2-carboxyethyl)-phenethylamino-5'-N-ethylcarboxamidoadenosine, and for adenosine A3 receptors, i.e. N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide, did not induce such effects. Because 5-fluorouracil is a cell cycle-specific drug damaging mainly cells in the S-phase, protective effects of CPA can be explained by its inhibitory action on the cell cycling. This interpretation was confirmed by experiments demonstrating that repeated administration of CPA in the hyperproliferation phase of the recovering haematopoiesis after 5-fluorouracil treatment inhibited transiently restoration of CFC-GM counts.


Subject(s)
Adenosine/analogs & derivatives , Adenosine/administration & dosage , Cell Proliferation/drug effects , Growth Inhibitors/administration & dosage , Hematopoietic Stem Cells/drug effects , Animals , Dose-Response Relationship, Drug , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred CBA
SELECTION OF CITATIONS
SEARCH DETAIL